Daiichi Sankyo Co., Ltd.

Daiichi Sankyo Co., Ltd. - formed in mid-2005 from the merger of Daiichi Pharmaceuticals Co., Ltd. and Sankyo Company, Ltd.

Related product monographs:

EGF receptor Mab, humanized, rDNA -- Japan mark.

RANKL Mab, rDNA -- Japan mark.

Location - Tokyo Japan For

Further information: